Copyright
©The Author(s) 2025.
World J Transplant. Sep 18, 2025; 15(3): 101997
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101997
Published online Sep 18, 2025. doi: 10.5500/wjt.v15.i3.101997
Figure 3 Proportion of transplanted patients by pre-median/post-median model for end-stage liver disease era at transplant era and race/ethnicity.
MMAT: Median model for end-stage liver disease era at transplant.
- Citation: Victor DW, Kodali S, Noureddin M, Brombosz EW, Lopez A, Basra T, Graviss EA, Nguyen DT, Saharia A, Connor AA, Abdelrahim M, Cheah YL, Simon CJ, Hobeika MJ, Mobley CM, Ghobrial RM. Disparities in liver transplantation for metabolic dysfunction-associated steatohepatitis-associated hepatocellular carcinoma. World J Transplant 2025; 15(3): 101997
- URL: https://www.wjgnet.com/2220-3230/full/v15/i3/101997.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i3.101997